Local and Regional Recurrences Following SABR in Stage I NSCLC: Diagnosis and Management
December 18, 2018 | Online

Overview

About this Program:

This one hour webinar will feature two presentations and a question/answer session.

Making a Diagnosis - David Palma, MD, PhD

This presentation will review the normal imaging findings after stereotactic radiation for lung cancer and will review strategies to diagnose recurrence and distinguish it from fibrosis.

Salvage Therapies and Outcomes - Eric Brooks, MD, MHS

Dr. Brooks will speak on how to select salvage therapy for patients who experience isolated local/regional recurrences of their early-stage NSCLC after SABR (up to 1 in 6 patients), and associated outcomes. This talk is aimed toward a large, multidisciplinary audience, including thoracic surgeons, oncologists, radiation oncologists, and interventional radiologists. The goal is to help inform clinicians of the management of these potentially curable but complex patients in routine clinical practice. 

Following the presentations, Suresh Senan MD, PhD, FRCR will moderate the question/answer session and lead the discussion.

What you should expect to learn

After attending this program learners will be able to:

  • Provide an update on the optimal management of patients with recurrent early-stage NSCLC following stereotactic radiation for lung cancer.
  • Review strategies to diagnose recurrence and distinguish it from fibrosis.
  • Address how to select salvage therapy for patients who experience recurrence after SABR.
  • Assess proposed or ongoing clinical trials that are likely to impact patient care in the near future.

Moderator:  Professor S. Senan  
MRCP, FRCR, PhD
Department of Radiation Oncology, 
Cancer Center Amsterdam
VU University Medical Center

 Dr. David Palma, MD, PhD

Radiation Oncologist,
London Health Sciences Centre
Clinician-Scientist, Ontario
Institute for Cancer Research

Eric Brooks, MD, MHS
Resident Physician
MD Anderson Cancer Center
Houston, TX, USA

Contact